Kun Du

Ms. Kun Du

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
KDKun Du
Kun Du
QZQinlong Zeng
Qinlong Zeng
MJMingjun Jiang
Mingjun Jiang
ZHZhiqing Hu
Zhiqing Hu
MZMiaojin Zhou
Miaojin Zhou
KXKun Xia
Kun Xia
Nucleic acid detection technology is crucial for molecular diagnosis. The advent of CRISPR/Cas12a-based nucleic acid detection has considerably broadened its scope, from the identification of infectious disease-causing microorganisms to the detection of disease-associated biomarkers. This innovative system capitalizes on the non-specific single-strand cleavage activity of Cas12a upon target DNA recognition. By employing a fluorescent probe in the form of a single-stranded DNA/RNA, this technology enables the observation of fluorescence changes resulting from nonspecific cleavage, thereby facilitating detection. CRISPR/Cas12a-based detection systems can be regarded as a new type of biosensor, offering a practical and efficient approach for nucleic acid analysis in various diagnostic settings. CRISPR/Cas12a-based biosensors outperform conventional nucleic acid detection methods in terms of portability, simplicity, speed, and efficiency. In this review, we elucidate the detection principle of CRISPR/Cas12a-based biosensors and their application in disease diagnostics and discuss recent innovations and technological challenges, aiming to provide insights for the research and further development of CRISPR/Cas12a-based biosensors in personalized medicine. Our findings show that although CRISPR/Cas12a-based biosensors have considerable potential for various applications and theoretical research, certain challenges remain. These include simplifying the reaction process, enhancing precision, broadening the scope of disease detection, and facilitating the translation of research findings into clinical practice. We anticipate that ongoing advancements in CRISPR/Cas12a-based biosensors will address these challenges.

9 August 2026 in ACS Sensors
Verified
Journal Article
Closed access
MZMiaojin Zhou
Miaojin Zhou
KDKun Du
Kun Du
MJMingjun Jiang
Mingjun Jiang
XXXin Xu
Xin Xu
XSXinran Su
Xinran Su
ZHZhiqing Hu
Zhiqing Hu